- Home
- CHMG vs AVIR Comparison
CHMG vs AVIR Comparison
Compare CHMG & AVIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHMG
- AVIR
- Stock Information
- Founded
- CHMG 1833
- AVIR 2012
- Country
- CHMG United States
- AVIR United States
- Employees
- CHMG N/A
- AVIR N/A
- Industry
- CHMG Major Banks
- AVIR Medicinal Chemicals and Botanical Products
- Sector
- CHMG Finance
- AVIR Health Care
- Exchange
- CHMG Nasdaq
- AVIR Nasdaq
- Market Cap
- CHMG 242.8M
- AVIR 239.1M
- IPO Year
- CHMG N/A
- AVIR 2020
- Fundamental
- Price
- CHMG $52.04
- AVIR $2.97
- Analyst Decision
- CHMG Hold
- AVIR Hold
- Analyst Count
- CHMG 3
- AVIR 1
- Target Price
- CHMG $56.33
- AVIR $6.00
- AVG Volume (30 Days)
- CHMG 5.7K
- AVIR 433.0K
- Earning Date
- CHMG 10-21-2025
- AVIR 11-12-2025
- Dividend Yield
- CHMG 2.64%
- AVIR N/A
- EPS Growth
- CHMG N/A
- AVIR N/A
- EPS
- CHMG 2.80
- AVIR N/A
- Revenue
- CHMG $86,610,000.00
- AVIR N/A
- Revenue This Year
- CHMG N/A
- AVIR N/A
- Revenue Next Year
- CHMG $32.65
- AVIR N/A
- P/E Ratio
- CHMG $18.44
- AVIR N/A
- Revenue Growth
- CHMG N/A
- AVIR N/A
- 52 Week Low
- CHMG $40.71
- AVIR $2.46
- 52 Week High
- CHMG $55.73
- AVIR $4.02
- Technical
- Relative Strength Index (RSI)
- CHMG 46.86
- AVIR 37.69
- Support Level
- CHMG $50.21
- AVIR $2.87
- Resistance Level
- CHMG $52.55
- AVIR $3.50
- Average True Range (ATR)
- CHMG 0.86
- AVIR 0.12
- MACD
- CHMG 0.09
- AVIR -0.02
- Stochastic Oscillator
- CHMG 30.31
- AVIR 13.49
About CHMG Chemung Financial Corp
Chemung Financial Corp is a bank holding firm. Through its subsidiaries, the company provides various financial services, including demand, savings, and time deposits, commercial, residential, and consumer loans, letters of credit, wealth management services, employee benefit plans, insurance products, mutual funds, and brokerage services, among others. The company's reportable segments are Core Banking, Wealth Management (WMG) services, and Holding company and CFS. Maximum revenue is generated from the Core Banking segment, which derives revenue by attracting deposits from the general public and using such funds to originate different types of loans, and to invest in securities. The Wealth Management (WMG) services segment provides trust and investment advisory services to clients.
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).